Skip to main content
Erschienen in: Supportive Care in Cancer 2/2018

27.09.2017 | Review Article

Bilateral vs. unilateral endoscopic ultrasound-guided celiac plexus neurolysis for abdominal pain management in patients with pancreatic malignancy: a systematic review and meta-analysis

verfasst von: Fan Lu, Jifu Dong, Yuming Tang, He Huang, Hui Liu, Li Song, Kexian Zhang

Erschienen in: Supportive Care in Cancer | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Context

Endoscopic ultrasound-guided celiac plexus neurolysis (EUS-CPN) by bilateral or unilateral approach is widely used in palliative abdominal pain management in pancreatic cancer patients, but the analgesic effect and relative risks of the two different puncture routes remain controversial.

Objectives

The aim of this systematic review was to evaluate the analgesic efficacy and safety of bilateral EUS-CPN compared with unilateral EUS-CPN.

Methods

An electronic database search was performed for randomized controlled trials comparing bilateral and unilateral approaches of EUS-CPN using the Pubmed, Cochrane Library, Web of Science, Google Scholar, and CNKI databases. Meta-analysis was performed using RevMan 5.3 after screening and methodological evaluation of the selected studies. Outcomes included pain relief, treatment response, analgesic reduction, complications, and quality of life (QOL).

Results

Six eligible studies involving 437 patients were included. No significant difference was found in short-term pain relief [SMD = 0.31, 95% CI (− 0.20, 0.81), P = 0.23] and response to treatment [RR = 0.99, 95% CI (0.77, 1.41), P = 0.97] between the bilateral and unilateral neurolysis groups. However, only the bilateral approach was associated with a statistically significant reduction in the postoperative use of analgesics [RR = 0.66, 95% CI (0.47, 0.94), P = 0.02] compared to the unilateral approach. A descriptive analysis was performed for complications and QOL.

Conclusion

The short-term analgesic effect and general risk of bilateral EUS-CPN are comparable with those of unilateral EUS-CPN, but our evidence supports the conclusion that the bilateral approach significantly reduces postoperative analgesic use.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
3.
Zurück zum Zitat Carrato A, Falcone A, Ducreux M et al (2015) A systematic review of the burden of pancreatic cancer in Europe: real-world impact on survival, quality of life and costs. J Gastrointest Cancer 46:201–211CrossRefPubMedPubMedCentral Carrato A, Falcone A, Ducreux M et al (2015) A systematic review of the burden of pancreatic cancer in Europe: real-world impact on survival, quality of life and costs. J Gastrointest Cancer 46:201–211CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat De Angelis R, Sant M, Coleman MP et al (2014) Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5—a population-based study. Lancet Oncol 15:23–34CrossRefPubMed De Angelis R, Sant M, Coleman MP et al (2014) Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5—a population-based study. Lancet Oncol 15:23–34CrossRefPubMed
5.
Zurück zum Zitat Sirri E, Castro FA, Kieschke J et al (2016) Recent trends in survival of patients with pancreatic cancer in Germany and the United States. Pancreas 45:908–914CrossRefPubMed Sirri E, Castro FA, Kieschke J et al (2016) Recent trends in survival of patients with pancreatic cancer in Germany and the United States. Pancreas 45:908–914CrossRefPubMed
6.
Zurück zum Zitat Morgan KA, Adams DB (2010) Solid tumors of the body and tail of the pancreas. Surg Clin North Am 90:287–307CrossRefPubMed Morgan KA, Adams DB (2010) Solid tumors of the body and tail of the pancreas. Surg Clin North Am 90:287–307CrossRefPubMed
7.
Zurück zum Zitat Yan BM, Myers RP (2007) Neurolytic celiac plexus block for pain control in unresectable pancreatic cancer. Am J Gastroenterol 102:430–438CrossRefPubMed Yan BM, Myers RP (2007) Neurolytic celiac plexus block for pain control in unresectable pancreatic cancer. Am J Gastroenterol 102:430–438CrossRefPubMed
8.
Zurück zum Zitat Singh P, Chaturvedi A (2015) Complementary and alternative medicine in cancer pain management: a systematic review. Indian J Palliat Care 21:105–115CrossRefPubMedPubMedCentral Singh P, Chaturvedi A (2015) Complementary and alternative medicine in cancer pain management: a systematic review. Indian J Palliat Care 21:105–115CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Smyth EN, Shen W, Bowman L et al (2016) Patient-reported pain and other quality of life domains as prognostic factors for survival in a phase III clinical trial of patients with advanced breast cancer. Health Qual Life Outcomes 14:52CrossRefPubMedPubMedCentral Smyth EN, Shen W, Bowman L et al (2016) Patient-reported pain and other quality of life domains as prognostic factors for survival in a phase III clinical trial of patients with advanced breast cancer. Health Qual Life Outcomes 14:52CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Kappis M (1914) Erfahrungen mit Lokalansthesie bei Bauchoperationen. Verh Dsch Ges Cire 43:87–89 Kappis M (1914) Erfahrungen mit Lokalansthesie bei Bauchoperationen. Verh Dsch Ges Cire 43:87–89
11.
12.
Zurück zum Zitat Moura RN, De Moura EG, Bernardo WM et al (2015) Endoscopic-ultrasound versus percutaneous-guided celiac plexus block for chronic pancreatitis pain. A systematic review and meta-analysis. Rev Gastroenterol Peru 35:333–341PubMed Moura RN, De Moura EG, Bernardo WM et al (2015) Endoscopic-ultrasound versus percutaneous-guided celiac plexus block for chronic pancreatitis pain. A systematic review and meta-analysis. Rev Gastroenterol Peru 35:333–341PubMed
13.
Zurück zum Zitat LeBlanc JK, Al-Haddad M, McHenry L et al (2011) A prospective, randomized study of EUS-guided celiac plexus neurolysis for pancreatic cancer: one injection or two? Gastrointest Endosc 74:1300–1307CrossRefPubMed LeBlanc JK, Al-Haddad M, McHenry L et al (2011) A prospective, randomized study of EUS-guided celiac plexus neurolysis for pancreatic cancer: one injection or two? Gastrointest Endosc 74:1300–1307CrossRefPubMed
14.
Zurück zum Zitat Higgins JPT, Green S (eds) (2011) The Cochrane Collaboration’s tool for assessing risk of bias. Part 2: general methods for Cochrane reviews. Cochrane handbook for systematic reviews of interventions. The Cochrane Collaboration. Available from http://handbook.cochrane.org Higgins JPT, Green S (eds) (2011) The Cochrane Collaboration’s tool for assessing risk of bias. Part 2: general methods for Cochrane reviews. Cochrane handbook for systematic reviews of interventions. The Cochrane Collaboration. Available from http://​handbook.​cochrane.​org
15.
Zurück zum Zitat Higgins JPT, Green S (eds) (2011) Extracting study results and converting to the desired format. Part 2: general methods for Cochrane reviews. The Cochrane Collaboration. Available from http://handbook.cochrane.org Higgins JPT, Green S (eds) (2011) Extracting study results and converting to the desired format. Part 2: general methods for Cochrane reviews. The Cochrane Collaboration. Available from http://​handbook.​cochrane.​org
16.
Zurück zum Zitat Bhatnagar S, Joshi S, Rana SP et al (2014) Bedside ultrasound-guided celiac plexus neurolysis in upper abdominal cancer patients: a randomized, prospective study for comparison of percutaneous bilateral paramedian vs. unilateral paramedian needle-insertion technique. Pain Pract 14:E63–E68CrossRefPubMed Bhatnagar S, Joshi S, Rana SP et al (2014) Bedside ultrasound-guided celiac plexus neurolysis in upper abdominal cancer patients: a randomized, prospective study for comparison of percutaneous bilateral paramedian vs. unilateral paramedian needle-insertion technique. Pain Pract 14:E63–E68CrossRefPubMed
17.
Zurück zum Zitat Tellez-Avila FI, Romano-Munive AF, Herrera-Esquivel Jde J, Ramirez-Luna MA (2013) Central is as effective as bilateral endoscopic ultrasound-guided celiac plexus neurolysis in patients with unresectable pancreatic cancer. Endosc Ultrasound 2:153–156CrossRefPubMedPubMedCentral Tellez-Avila FI, Romano-Munive AF, Herrera-Esquivel Jde J, Ramirez-Luna MA (2013) Central is as effective as bilateral endoscopic ultrasound-guided celiac plexus neurolysis in patients with unresectable pancreatic cancer. Endosc Ultrasound 2:153–156CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat LeBlanc JK, DeWitt J, Johnson C et al (2009) A prospective randomized trial of 1 versus 2 injections during EUS-guided celiac plexus block for chronic pancreatitis pain. Gastrointest Endosc 69:835–842CrossRefPubMed LeBlanc JK, DeWitt J, Johnson C et al (2009) A prospective randomized trial of 1 versus 2 injections during EUS-guided celiac plexus block for chronic pancreatitis pain. Gastrointest Endosc 69:835–842CrossRefPubMed
19.
Zurück zum Zitat Ascunce G, Ribeiro A, Reis I et al (2011) EUS visualization and direct celiac ganglia neurolysis predicts better pain relief in patients with pancreatic malignancy (with video). Gastrointest Endosc 73:267–274CrossRefPubMed Ascunce G, Ribeiro A, Reis I et al (2011) EUS visualization and direct celiac ganglia neurolysis predicts better pain relief in patients with pancreatic malignancy (with video). Gastrointest Endosc 73:267–274CrossRefPubMed
20.
Zurück zum Zitat Sahai AV, Lemelin V, Lam E, Paquin SC (2009) Central vs. bilateral endoscopic ultrasound-guided celiac plexus block or neurolysis: a comparative study of short-term effectiveness. Am J Gastroenterol 104:326–329CrossRefPubMed Sahai AV, Lemelin V, Lam E, Paquin SC (2009) Central vs. bilateral endoscopic ultrasound-guided celiac plexus block or neurolysis: a comparative study of short-term effectiveness. Am J Gastroenterol 104:326–329CrossRefPubMed
21.
Zurück zum Zitat Loukas M, Klaassen Z, Merbs W et al (2010) A review of the thoracic splanchnic nerves and celiac ganglia. Clin Anat 23:512–522CrossRefPubMed Loukas M, Klaassen Z, Merbs W et al (2010) A review of the thoracic splanchnic nerves and celiac ganglia. Clin Anat 23:512–522CrossRefPubMed
22.
Zurück zum Zitat Kambadakone A, Thabet A, Gervais DA, Mueller PR, Arellano RS (2011) CT-guided celiac plexus neurolysis: a review of anatomy, indications, technique, and tips for successful treatment. Radiographics 31:1599–1621CrossRefPubMed Kambadakone A, Thabet A, Gervais DA, Mueller PR, Arellano RS (2011) CT-guided celiac plexus neurolysis: a review of anatomy, indications, technique, and tips for successful treatment. Radiographics 31:1599–1621CrossRefPubMed
23.
Zurück zum Zitat Pereira GA, Lopes PT, Dos Santos AM et al (2014) Celiac plexus block: an anatomical study and simulation using computed tomography. Radiol Bras 47:283–287CrossRefPubMedPubMedCentral Pereira GA, Lopes PT, Dos Santos AM et al (2014) Celiac plexus block: an anatomical study and simulation using computed tomography. Radiol Bras 47:283–287CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat De Cicco M, Matovic M, Bortolussi R et al (2001) Celiac plexus block: injectate spread and pain relief in patients with regional anatomic distortions. Anesthesiology 94:561–265CrossRefPubMed De Cicco M, Matovic M, Bortolussi R et al (2001) Celiac plexus block: injectate spread and pain relief in patients with regional anatomic distortions. Anesthesiology 94:561–265CrossRefPubMed
26.
Zurück zum Zitat Brown DL, Bulley CK, Quiel EL (1987) Neurolytic celiac plexus block for pancreatic cancer pain. Anesth Analg 66:869–873PubMed Brown DL, Bulley CK, Quiel EL (1987) Neurolytic celiac plexus block for pancreatic cancer pain. Anesth Analg 66:869–873PubMed
27.
Zurück zum Zitat Kaufman M, Singh G, Das S et al (2010) Efficacy of endoscopic ultrasound-guided celiac plexus block and celiac plexus neurolysis for managing abdominal pain associated with chronic pancreatitis and pancreatic cancer. J Clin Gastroenterol 44:127–134CrossRefPubMed Kaufman M, Singh G, Das S et al (2010) Efficacy of endoscopic ultrasound-guided celiac plexus block and celiac plexus neurolysis for managing abdominal pain associated with chronic pancreatitis and pancreatic cancer. J Clin Gastroenterol 44:127–134CrossRefPubMed
28.
Zurück zum Zitat Wyse JM, Carone M, Paquin SC, Usatii M, Sahai AV (2011) Randomized, double-blind, controlled trial of early endoscopic ultrasound-guided celiac plexus neurolysis to prevent pain progression in patients with newly diagnosed, painful, inoperable pancreatic cancer. J Clin Oncol 29:3541–3546CrossRefPubMed Wyse JM, Carone M, Paquin SC, Usatii M, Sahai AV (2011) Randomized, double-blind, controlled trial of early endoscopic ultrasound-guided celiac plexus neurolysis to prevent pain progression in patients with newly diagnosed, painful, inoperable pancreatic cancer. J Clin Oncol 29:3541–3546CrossRefPubMed
29.
Zurück zum Zitat McGreevy K, Hurley RW, Erdek MA et al (2013) The effectiveness of repeat celiac plexus neurolysis for pancreatic cancer: a pilot study. Pain Pract 13:89–95CrossRefPubMed McGreevy K, Hurley RW, Erdek MA et al (2013) The effectiveness of repeat celiac plexus neurolysis for pancreatic cancer: a pilot study. Pain Pract 13:89–95CrossRefPubMed
30.
Zurück zum Zitat Wang KX, Jin ZD, Du YQ et al (2012) EUS-guided celiac ganglion irradiation with iodine-125 seeds for pain control in pancreatic carcinoma: a prospective pilot study. Gastrointest Endosc 76:945–952CrossRefPubMed Wang KX, Jin ZD, Du YQ et al (2012) EUS-guided celiac ganglion irradiation with iodine-125 seeds for pain control in pancreatic carcinoma: a prospective pilot study. Gastrointest Endosc 76:945–952CrossRefPubMed
Metadaten
Titel
Bilateral vs. unilateral endoscopic ultrasound-guided celiac plexus neurolysis for abdominal pain management in patients with pancreatic malignancy: a systematic review and meta-analysis
verfasst von
Fan Lu
Jifu Dong
Yuming Tang
He Huang
Hui Liu
Li Song
Kexian Zhang
Publikationsdatum
27.09.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 2/2018
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-017-3888-0

Weitere Artikel der Ausgabe 2/2018

Supportive Care in Cancer 2/2018 Zur Ausgabe

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Bessere Prognose mit links- statt rechtsseitigem Kolon-Ca.

06.05.2024 Kolonkarzinom Nachrichten

Menschen mit linksseitigem Kolonkarzinom leben im Mittel zweieinhalb Jahre länger als solche mit rechtsseitigem Tumor. Auch aktuell ist das Sterberisiko bei linksseitigen Tumoren US-Daten zufolge etwa um 11% geringer als bei rechtsseitigen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.